Bringing the fundamentals into focus…
Back to Alnylam Pharmaceuticals, Inc.
How Alnylam Pharmaceuticals, Inc. stacks up
ALNY · against 454 other Healthcare companies listed in US-listed
Growth
97/ 100
Near the top of its peers.
Ranked #17 of 455 · scores higher than 96% of peers
Bars: peers in each 10-point band of the growth score85 peers with a growth score of 90–100, including ALNY · Click a bar to see the companies
Why growth scores 97?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth, 3-year revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
- Earnings per share turned from a loss to a profit. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 93% of peers. 3-year revenue growth: 57.2% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 94% of peers. Revenue growth: 95.1% vs peer median 6.1%
Metric by metric
Position: dot = ALNY, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ALNY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 95.1% | 11.0% | 89% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | 57.2% | 11.0% | 87% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around ALNY| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 12 | 3.8B USD | 98 | 71 | |
| 12 | 914M USD | 98 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score